Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Aug;69(4):689–692. doi: 10.1111/j.1476-5381.1980.tb07923.x

Structure-activity studies with neurotensin: analysis of positions 9, 10 and 11.

R Quirion, D Regoli, F Rioux, S St-Pierre
PMCID: PMC2044307  PMID: 7437646

Abstract

1 The stimulant effects of neurotensin (NT) and NT analogues modified in positions 9, 10 or 11 were evaluated and compared in two pharmacological preparations: the rat stomach strip and the isolated spontaneously beating atria of guinea-pig. 2 The data derived from our structure-activity study suggest that Arg9 and Pro10 mainly contribute to the affinity of neurotensin for its cardiac and smooth muscle receptors. Tyr11 seems to be more closely involved in the process of receptor activation by NT. 3 The order of potency of some NT analogues modified in position 11 (e.g. [D-Phe11]-NT, [D-Tyr11]-NT) was strikingly different from that described in other systems (e.g. hypothermia test and specific mast cell binding). The importance of this observation is discussed.

Full text

PDF
689

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bissette G., Manberg P., Nemeroff C. B., Prange A. J., Jr Neurotensin, a biologically active peptide. Life Sci. 1978 Nov 27;23(22):2173–2182. doi: 10.1016/0024-3205(78)90201-1. [DOI] [PubMed] [Google Scholar]
  2. Carraway R., Leeman S. E. Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. J Biol Chem. 1976 Nov 25;251(22):7045–7052. [PubMed] [Google Scholar]
  3. Carraway R., Leeman S. E. Radioimmunoassay for neurotensin, a hypothalamic peptide. J Biol Chem. 1976 Nov 25;251(22):7035–7044. [PubMed] [Google Scholar]
  4. Carraway R., Leeman S. E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973 Oct 10;248(19):6854–6861. [PubMed] [Google Scholar]
  5. Quirion R., Regoli D., Rioux F., St-Pierre S. The stimulatory effects of neurotensin and related peptides in rat stomach strips and guinea-pig atria. Br J Pharmacol. 1980 Jan;68(1):83–91. doi: 10.1111/j.1476-5381.1980.tb10702.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Regoli D., Park W. K., Rioux F. Pharmacology of angiotensin. Pharmacol Rev. 1974 Jun;26(2):69–123. [PubMed] [Google Scholar]
  7. Rivier J. E., Lazarus L. H., Perrin M. H., Brown M. R. Neurotensin analogues. Structure--activity relationships. J Med Chem. 1977 Nov;20(11):1409–1412. doi: 10.1021/jm00221a011. [DOI] [PubMed] [Google Scholar]
  8. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES